Alicia Hager

Dr. Hager joined Nkarta as Chief Legal Officer in 2020 and is responsible for directing the company’s legal affairs. She was previously at OncoMed Pharmaceuticals for nearly eleven years, where she held multiple roles of increasing responsibility, serving most recently as Senior Vice President and General Counsel. During her tenure at OncoMed, she negotiated major strategic partnerships, helped lead the company through its IPO, and oversaw a cross-border merger. Prior to joining OncoMed, Dr. Hager was an attorney at the law firm of Morrison & Foerster LLP, where she served as intellectual property counsel to biotech and pharmaceutical clients. Early in her career, Dr. Hager was a patent agent at the law firm of Heller Ehrman White & McAuliffe LLP.

Dr. Hager received a JD from Stanford Law School, a PhD in Chemistry from Harvard University, and an AB in Chemistry from Occidental College.